This brand name is authorized in Austria, Cyprus, Estonia, Spain, Finland, France, Hong Kong, Ireland, Lithuania, Poland, Romania, United Kingdom
The drug RAPISCAN contains one active pharmaceutical ingredient (API):
|
1
Regadenoson
UNII 2XLN4Y044H - REGADENOSON
|
|
Regadenoson is a low affinity agonist (Ki ≈ 1.3 μM) for the A2A adenosine receptor, with at least 10-fold lower affinity for the A1 adenosine receptor (Ki >16.5 μM), and very low, if any, affinity for the A2B and A3 adenosine receptors. Activation of the A2A adenosine receptor produces coronary vasodilation and increases coronary blood flow (CBF). |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| RAPISCAN Solution for injection | European Medicines Agency (EU) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| C01EB21 | C Cardiovascular system → C01 Cardiac therapy → C01E Other cardiac preparations → C01EB Other cardiac preparations | |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: EE | Ravimiamet | Identifier(s): 1493939 |
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 110643001 |
| Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 506963 |
| Country: FR | Base de données publique des médicaments | Identifier(s): 69075222 |
| Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 194865 |
| Country: HK | Department of Health Drug Office | Identifier(s): 66576 |
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1056396 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100315321 |
| Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W64487001 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
